Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD , RAINBOW , and RAINFALL Phase III Studies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from
REGARD
,
RAINBOW
, and
RAINFALL
Phase
III
Studies
Authors
Keywords
-
Journal
ONCOLOGIST
Volume 26, Issue 9, Pages -
Publisher
Wiley
Online
2021-05-26
DOI
10.1002/onco.13836
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer: A Phase III Randomized Controlled Trial
- (2021) Zhihao Lu et al. JOURNAL OF CLINICAL ONCOLOGY
- Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2019) Charles S Fuchs et al. LANCET ONCOLOGY
- Clinicopathological Characteristics and Prognosis of cT1N0M1 Gastric Cancer: A Population-Based Study
- (2019) Jianbo Han et al. DISEASE MARKERS
- Impact of weight loss and sarcopenia on response to chemotherapy, quality of life and survival
- (2019) Aoife M Ryan et al. NUTRITION
- Precision medicine in gastric cancer
- (2019) Patrizia Bonelli et al. World Journal of Gastrointestinal Oncology
- Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: A systemic review and meta-analysis
- (2019) Ling-Nan Zheng et al. World Journal of Clinical Cases
- Risk factors for severe weight loss at 1 month after gastrectomy for gastric cancer
- (2018) Kenki Segami et al. Asian Journal of Surgery
- Impact of body mass index on surgical outcomes of gastric cancer
- (2018) Fan Feng et al. BMC CANCER
- Prognostic Roles of Perioperative Body Mass Index and Weight Loss in the Long-Term Survival of Gastric Cancer Patients
- (2018) Young Suk Park et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer
- (2017) Toru Aoyama et al. International Journal of Clinical Oncology
- Weight Loss During Initial Chemotherapy Predicts Survival in Patients With Advanced Gastric Cancer
- (2017) Kotoe Takayoshi et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Progress in the treatment of advanced gastric cancer
- (2017) Zheyu Song et al. TUMOR BIOLOGY
- Gastric cancer, nutritional status, and outcome
- (2017) Xuechao Liu et al. OncoTargets and Therapy
- Outcome predictors for patients with stage II/III gastric cancer who undergo gastrectomy and S-1 adjuvant chemotherapy
- (2017) Yoshinori Fujiwara et al. Oncology Letters
- Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data
- (2017) Charles S. Fuchs et al. Journal of Gastric Cancer
- Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma
- (2016) S.-E. Al-Batran et al. ANNALS OF ONCOLOGY
- Patterns and Predictors of Weight Loss After Gastrectomy for Cancer
- (2016) Jeremy L. Davis et al. ANNALS OF SURGICAL ONCOLOGY
- Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer
- (2015) Chan-Young Ock et al. Gastric Cancer
- Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario
- (2014) Matthew Dixon et al. Gastric Cancer
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Gastric Cancer: Current Status of Diagnosis and Treatment
- (2013) Tsunehiro Takahashi et al. Cancers
- The quality of life trajectory of resected gastric cancer
- (2011) Gitonga Munene et al. JOURNAL OF SURGICAL ONCOLOGY
- A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy
- (2010) D. Kanagavel et al. ANNALS OF ONCOLOGY
- Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2
- (2010) Jennifer L. Spratlin et al. JOURNAL OF CLINICAL ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started